Hydrogenics sees Q1 revenue below consensus, shares -11%

Hydrogenics (HYGS -11.3%) shares plunge in apparent reaction to Friday's report of preliminary Q1 revenue of $7M-$7.5M vs. analyst expectations of $11.7M.

HYGS reiterated its previously announced FY 2014 outlook that it will exceed $50M in revenue and will surpass breakeven adjusted EBITDA for the year.

Says it finished 2013 with $57M backlog, with ~$40M to be realized as revenue in 2014.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs